Literature DB >> 3284678

Bone morphogenetic protein augmentation grafting of resistant femoral nonunions. A preliminary report.

E E Johnson1, M R Urist, G A Finerman.   

Abstract

Twelve patients with intractable nonunions of the femoral diaphyseal or metaphyseal-diaphyseal shaft were successfully treated by a combination of internal fixation and implants of human bone morphogenetic protein (h-BMP). There was an average of 4.3 surgical procedures per patient attempting union prior to h-BMP implantation. Union was obtained in 11 of 12 patients and in one patient with a repeat stabilization and implantation of h-BMP. Four patients received autogeneic cancellous bone graft and four patients received allogeneic bone grafts. The BMP implant was prepared in the form of an aggregate of h-BMP and bone matrix water-insoluble noncollagenous proteins (h-BMP/iNCP). Fifty to 100 mg of h-BMP/iNCP was either implanted in the fracture gap in ultra thin gelatin capsules, or incorporated in a strip of polylactic/polyglycolic acid copolymer (PLA/PGA) and placed as an onlay across the fracture gap. The average time to union was 4.7 months. Further clinical investigations are planned as a series of matched cases with and without BMP augmentation in order to distinguish h-BMP effects from new or improved methods of fracture fixation combined with autogeneic cancellous bone grafts.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3284678

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  17 in total

1.  Extraction and characterization of native canine bone morphogenetic protein (cBMP) qualified with osteoinductivity.

Authors:  J Oksanen; A Marttinen; S Paatsama; T S Lindholm
Journal:  Acta Vet Scand       Date:  1998       Impact factor: 1.695

Review 2.  [Osteoinduction and -reparation].

Authors:  N R Kübler
Journal:  Mund Kiefer Gesichtschir       Date:  1997-02

3.  Marshall R. Urist and the discovery of bone morphogenetic proteins.

Authors:  Lovorka Grgurevic; Marko Pecina; Slobodan Vukicevic
Journal:  Int Orthop       Date:  2017-02-11       Impact factor: 3.075

4.  [Therapy-resistant, atrophic and septic femoral pseudarthrosis].

Authors:  C Wedemeyer; R Peppmüller; T Bredendiek
Journal:  Orthopade       Date:  2011-05       Impact factor: 1.087

Review 5.  Growth factor delivery: how surface interactions modulate release in vitro and in vivo.

Authors:  William J King; Paul H Krebsbach
Journal:  Adv Drug Deliv Rev       Date:  2012-03-10       Impact factor: 15.470

6.  Long-term safety and efficacy of human bone morphogenetic protein (HBMP) in the treatment of resistant non-unions and failed arthrodesis.

Authors:  Arya Nick Shamie; Hamed Yazdanshenas; Eric Egan Johnson
Journal:  J Clin Orthop Trauma       Date:  2016-11-16

Review 7.  Biotechnology and bone graft substitutes.

Authors:  R A Kenley; K Yim; J Abrams; E Ron; T Turek; L J Marden; J O Hollinger
Journal:  Pharm Res       Date:  1993-10       Impact factor: 4.200

Review 8.  Bone morphogenetic protein use in spine surgery-complications and outcomes: a systematic review.

Authors:  Antonio Faundez; Clément Tournier; Matthieu Garcia; Stéphane Aunoble; Jean-Charles Le Huec
Journal:  Int Orthop       Date:  2016-03-10       Impact factor: 3.075

Review 9.  The role of morphogens in endochondral ossification.

Authors:  J T Campbell; F S Kaplan
Journal:  Calcif Tissue Int       Date:  1992-03       Impact factor: 4.333

Review 10.  Bone morphogenetic protein: a review.

Authors:  G Aldinger; G Herr; W Küsswetter; H J Reis; F W Thielemann; U Holz
Journal:  Int Orthop       Date:  1991       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.